Latest News & Upcoming Events
MacuLogix Introduces the AdaptDx Pro Guided by Theia
MacuLogix, Inc. announces the next generation of dark adaptation functional testing with the introduction of the AdaptDx Pro guided by Theia.
Read Press ReleaseMacuLogix Hires Christine W. Silverberg as Director of National Accounts
Christine Silverberg will expand the company’s strategic partnerships with key players in the eye care industry.
Read Press Release“Practical Strategies for Preventing Blindness Caused by AMD” is Released
New report includes a definitive statement on best practices written by a team of 27 leading optometrists.
Read Press ReleaseMacuLogix Appoints Senior Vice President of Finance
Mr. Dorsey will oversee all aspects of financial operations and lead the overall fiscal strategy to further strengthen the company’s positioning and enhance value.
Read Press ReleaseMacuLogix Raises $38.7 Million in Series D Financing Led by Vivo Capital
This funding will be used to further expand the team and company infrastructure to support the growing sales and practice integration efforts of the AdaptDx automated dark adaptometer.
Read Press ReleaseMacuLogix New HQ Announcement
The new headquarters occupies 17,400 square feet of space and was designed as a bright and welcoming environment to accommodate their current and future needs.
Read Press ReleaseMacuLogix Hosts Inaugural AMD Speaker Alliance
MacuLogix proudly hosted the industry’s first AMD Speaker Alliance meeting in January 2019 at the Hotel Hershey which was filled with prestigious and knowledgeable eye care professionals.
Read Press ReleaseMacuLogix Enters International Distribution Agreement with Optos
By expanding the MacuLogix distribution network to include eight new countries, the AdaptDx will reach an additional 260 million people. Partnering with the Optos team will help the company achieve its bold vision of eliminating blindness caused by AMD.
Read Press ReleaseMacuLogix Enters Canadian Distribution Agreement with Clarion Medical Technologies
The AdaptDx is an exciting addition to Clarion’s expansive portfolio of revolutionary ophthalmic devices, lenses, and nutraceuticals.
Read Press ReleaseMacuLogix Launches the AdaptDx in Europe at EURETINA
“Introducing the AdaptDx to the European eyecare community during EURETINA is a major milestone for our company,” said William McPhee, president and CEO of MacuLogix.
Read Press Release